Carol A. Watson

Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding

Pancras C. Wong, Dietmar Seiffert, J. Eileen Bird et al. · Science Translational Medicine · 2017 · 144 citations

Immunology, Pharmacotherapy, Platelet Aggregation +21

Tetrahydroquinoline Derivatives as Potent and Selective Factor XIa Inhibitors

Mimi L. Quan, Pancras C. Wong, Cailan Wang et al. · Journal of Medicinal Chemistry · 2014 · 76 citations · Full text

Rabbit Thrombosis Models, Pharmacotherapy, Pharmaceutical Chemistry +18

A small-molecule factor XIa inhibitor produces antithrombotic efficacy with minimal bleeding time prolongation in rabbits

Pancras C. Wong, Earl J. Crain, Carol A. Watson et al. · Journal of Thrombosis and Thrombolysis · 2011 · 73 citations

Thrombosis, Blood Platelet, Medicine +9

Nonpeptide Factor Xa Inhibitors: I. Studies with SF303 and SK549, a New Class of Potent Antithrombotics

Pancras C. Wong, Mimi L. Quan, Earl J. Crain et al. · Journal of Pharmacology and Experimental Therapeutics · 2000 · 71 citations

Favorable therapeutic index of the direct factor Xa inhibitors, apixaban and rivaroxaban, compared with the thrombin inhibitor dabigatran in rabbits

Pancras C. Wong, Earl J. Crain, Carol A. Watson et al. · Journal of Thrombosis and Haemostasis · 2009 · 68 citations

Thrombosis, Thrombin Inhibitor Dabigatran, Hematology +9